The global market size was valued at US$ 13.56 billion in 2024 and is projected to reach US$ 28.92 billion by 2030, at a CAGR of 13.5% during the forecast period 2024-2030.
The United States market size was valued at US$ 4.89 billion in 2024 and is projected to reach US$ 10.23 billion by 2030, at a CAGR of 13.1% during the forecast period 2024-2030.
Advanced therapeutic approaches using cellular and tissue engineering technologies.
The market experiences rapid growth, driven by regenerative medicine advances. In 2023, clinical trials reached 925, with oncology applications leading at 48%. Autologous therapies grow at 15.2% annually. Market saw 55% increase in commercial approvals. Regulatory frameworks established in 42 countries. Future investments of US$ 9.45 billion planned by 2026. North America leads with 46% market share.
Report Overview
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules.
This report provides a deep insight into the global Cell Therapy and Tissue Engineering market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell Therapy and Tissue Engineering Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell Therapy and Tissue Engineering market in any manner.
Global Cell Therapy and Tissue Engineering Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Betalin Therapeutics
- BioCardia, Inc
- BioReliance Corporation
- Biosolution Co.
- Brainstorm Cell Therapeutics, Inc
- MaxCyte, Inc
- Medigene AG
- MEDIPOST CO.
- Mesoblast Limited
- Miromatrix Medical, Inc.
- MolMed S.p.A
- Mustang Bio, Inc
- NantKwest, Inc.
- Neuralstem, Inc
- NexImmune, Inc.
- Nohla Therapeutics, Inc
- ReNeuron Group plc
- Richter-Helm BioLogics GmbH & Co. KG
- RoosterBio, Inc
- RoslinCT
- Rubius Therapeutics, Inc.
- Sangamo Therapeutics, Inc
- Voyager Therapeutics, Inc
- Waisman Biomanufacturing
- WindMIL Therapeutics, Inc.
- Wuxi App Tec, Inc.
- ReNeuron Group plc
- Richter-Helm BioLogics GmbH & Co. KG
- RoosterBio, Inc
- RoslinCT
Market Segmentation (by Type)
- Cell Therapy
- Tissue Engineering
- Market Segmentation (by Application)
- Cell Defects
- Genetic Diseases
- Neurodegenerative Diseases
- Tissue Malignancies
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cell Therapy and Tissue Engineering Market
Overview of the regional outlook of the Cell Therapy and Tissue Engineering Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cell Therapy and Tissue Engineering
1.2 Key Market Segments
1.2.1 Cell Therapy and Tissue Engineering Segment by Type
1.2.2 Cell Therapy and Tissue Engineering Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cell Therapy and Tissue Engineering Market Overview
2.1 Global Market Overview
2.1.1 Global Cell Therapy and Tissue Engineering Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cell Therapy and Tissue Engineering Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cell Therapy and Tissue Engineering Market Competitive Landscape
3.1 Global Cell Therapy and Tissue Engineering Sales by Manufacturers (2019-2024)
3.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell Therapy and Tissue Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell Therapy and Tissue Engineering Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell Therapy and Tissue Engineering Sales Sites, Area Served, Product Type
3.6 Cell Therapy and Tissue Engineering Market Competitive Situation and Trends
3.6.1 Cell Therapy and Tissue Engineering Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell Therapy and Tissue Engineering Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cell Therapy and Tissue Engineering Industry Chain Analysis
4.1 Cell Therapy and Tissue Engineering Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cell Therapy and Tissue Engineering Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cell Therapy and Tissue Engineering Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell Therapy and Tissue Engineering Sales Market Share by Type (2019-2024)
6.3 Global Cell Therapy and Tissue Engineering Market Size Market Share by Type (2019-2024)
6.4 Global Cell Therapy and Tissue Engineering Price by Type (2019-2024)
7 Cell Therapy and Tissue Engineering Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell Therapy and Tissue Engineering Market Sales by Application (2019-2024)
7.3 Global Cell Therapy and Tissue Engineering Market Size (M USD) by Application (2019-2024)
7.4 Global Cell Therapy and Tissue Engineering Sales Growth Rate by Application (2019-2024)
8 Cell Therapy and Tissue Engineering Market Segmentation by Region
8.1 Global Cell Therapy and Tissue Engineering Sales by Region
8.1.1 Global Cell Therapy and Tissue Engineering Sales by Region
8.1.2 Global Cell Therapy and Tissue Engineering Sales Market Share by Region
8.2 North America
8.2.1 North America Cell Therapy and Tissue Engineering Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell Therapy and Tissue Engineering Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell Therapy and Tissue Engineering Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell Therapy and Tissue Engineering Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell Therapy and Tissue Engineering Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Betalin Therapeutics
9.1.1 Betalin Therapeutics Cell Therapy and Tissue Engineering Basic Information
9.1.2 Betalin Therapeutics Cell Therapy and Tissue Engineering Product Overview
9.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Product Market Performance
9.1.4 Betalin Therapeutics Business Overview
9.1.5 Betalin Therapeutics Cell Therapy and Tissue Engineering SWOT Analysis
9.1.6 Betalin Therapeutics Recent Developments
9.2 BioCardia, Inc
9.2.1 BioCardia, Inc Cell Therapy and Tissue Engineering Basic Information
9.2.2 BioCardia, Inc Cell Therapy and Tissue Engineering Product Overview
9.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Product Market Performance
9.2.4 BioCardia, Inc Business Overview
9.2.5 BioCardia, Inc Cell Therapy and Tissue Engineering SWOT Analysis
9.2.6 BioCardia, Inc Recent Developments
9.3 BioReliance Corporation
9.3.1 BioReliance Corporation Cell Therapy and Tissue Engineering Basic Information
9.3.2 BioReliance Corporation Cell Therapy and Tissue Engineering Product Overview
9.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Product Market Performance
9.3.4 BioReliance Corporation Cell Therapy and Tissue Engineering SWOT Analysis
9.3.5 BioReliance Corporation Business Overview
9.3.6 BioReliance Corporation Recent Developments
9.4 Biosolution Co.
9.4.1 Biosolution Co. Cell Therapy and Tissue Engineering Basic Information
9.4.2 Biosolution Co. Cell Therapy and Tissue Engineering Product Overview
9.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Product Market Performance
9.4.4 Biosolution Co. Business Overview
9.4.5 Biosolution Co. Recent Developments
9.5 Brainstorm Cell Therapeutics, Inc
9.5.1 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Basic Information
9.5.2 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product Overview
9.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product Market Performance
9.5.4 Brainstorm Cell Therapeutics, Inc Business Overview
9.5.5 Brainstorm Cell Therapeutics, Inc Recent Developments
9.6 MaxCyte, Inc
9.6.1 MaxCyte, Inc Cell Therapy and Tissue Engineering Basic Information
9.6.2 MaxCyte, Inc Cell Therapy and Tissue Engineering Product Overview
9.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Product Market Performance
9.6.4 MaxCyte, Inc Business Overview
9.6.5 MaxCyte, Inc Recent Developments
9.7 Medigene AG
9.7.1 Medigene AG Cell Therapy and Tissue Engineering Basic Information
9.7.2 Medigene AG Cell Therapy and Tissue Engineering Product Overview
9.7.3 Medigene AG Cell Therapy and Tissue Engineering Product Market Performance
9.7.4 Medigene AG Business Overview
9.7.5 Medigene AG Recent Developments
9.8 MEDIPOST CO.
9.8.1 MEDIPOST CO. Cell Therapy and Tissue Engineering Basic Information
9.8.2 MEDIPOST CO. Cell Therapy and Tissue Engineering Product Overview
9.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Product Market Performance
9.8.4 MEDIPOST CO. Business Overview
9.8.5 MEDIPOST CO. Recent Developments
9.9 Mesoblast Limited
9.9.1 Mesoblast Limited Cell Therapy and Tissue Engineering Basic Information
9.9.2 Mesoblast Limited Cell Therapy and Tissue Engineering Product Overview
9.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Product Market Performance
9.9.4 Mesoblast Limited Business Overview
9.9.5 Mesoblast Limited Recent Developments
9.10 Miromatrix Medical, Inc.
9.10.1 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Basic Information
9.10.2 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product Overview
9.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product Market Performance
9.10.4 Miromatrix Medical, Inc. Business Overview
9.10.5 Miromatrix Medical, Inc. Recent Developments
9.11 MolMed S.p.A
9.11.1 MolMed S.p.A Cell Therapy and Tissue Engineering Basic Information
9.11.2 MolMed S.p.A Cell Therapy and Tissue Engineering Product Overview
9.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Product Market Performance
9.11.4 MolMed S.p.A Business Overview
9.11.5 MolMed S.p.A Recent Developments
9.12 Mustang Bio, Inc
9.12.1 Mustang Bio, Inc Cell Therapy and Tissue Engineering Basic Information
9.12.2 Mustang Bio, Inc Cell Therapy and Tissue Engineering Product Overview
9.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Product Market Performance
9.12.4 Mustang Bio, Inc Business Overview
9.12.5 Mustang Bio, Inc Recent Developments
9.13 NantKwest, Inc.
9.13.1 NantKwest, Inc. Cell Therapy and Tissue Engineering Basic Information
9.13.2 NantKwest, Inc. Cell Therapy and Tissue Engineering Product Overview
9.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Product Market Performance
9.13.4 NantKwest, Inc. Business Overview
9.13.5 NantKwest, Inc. Recent Developments
9.14 Neuralstem, Inc
9.14.1 Neuralstem, Inc Cell Therapy and Tissue Engineering Basic Information
9.14.2 Neuralstem, Inc Cell Therapy and Tissue Engineering Product Overview
9.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Product Market Performance
9.14.4 Neuralstem, Inc Business Overview
9.14.5 Neuralstem, Inc Recent Developments
9.15 NexImmune, Inc.
9.15.1 NexImmune, Inc. Cell Therapy and Tissue Engineering Basic Information
9.15.2 NexImmune, Inc. Cell Therapy and Tissue Engineering Product Overview
9.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Product Market Performance
9.15.4 NexImmune, Inc. Business Overview
9.15.5 NexImmune, Inc. Recent Developments
9.16 Nohla Therapeutics, Inc
9.16.1 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Basic Information
9.16.2 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product Overview
9.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product Market Performance
9.16.4 Nohla Therapeutics, Inc Business Overview
9.16.5 Nohla Therapeutics, Inc Recent Developments
9.17 ReNeuron Group plc
9.17.1 ReNeuron Group plc Cell Therapy and Tissue Engineering Basic Information
9.17.2 ReNeuron Group plc Cell Therapy and Tissue Engineering Product Overview
9.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Product Market Performance
9.17.4 ReNeuron Group plc Business Overview
9.17.5 ReNeuron Group plc Recent Developments
9.18 Richter-Helm BioLogics GmbH and Co. KG
9.18.1 Richter-Helm BioLogics GmbH and Co. KG Cell Therapy and Tissue Engineering Basic Information
9.18.2 Richter-Helm BioLogics GmbH and Co. KG Cell Therapy and Tissue Engineering Product Overview
9.18.3 Richter-Helm BioLogics GmbH and Co. KG Cell Therapy and Tissue Engineering Product Market Performance
9.18.4 Richter-Helm BioLogics GmbH and Co. KG Business Overview
9.18.5 Richter-Helm BioLogics GmbH and Co. KG Recent Developments
9.19 RoosterBio, Inc
9.19.1 RoosterBio, Inc Cell Therapy and Tissue Engineering Basic Information
9.19.2 RoosterBio, Inc Cell Therapy and Tissue Engineering Product Overview
9.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Product Market Performance
9.19.4 RoosterBio, Inc Business Overview
9.19.5 RoosterBio, Inc Recent Developments
9.20 RoslinCT
9.20.1 RoslinCT Cell Therapy and Tissue Engineering Basic Information
9.20.2 RoslinCT Cell Therapy and Tissue Engineering Product Overview
9.20.3 RoslinCT Cell Therapy and Tissue Engineering Product Market Performance
9.20.4 RoslinCT Business Overview
9.20.5 RoslinCT Recent Developments
9.21 Rubius Therapeutics, Inc.
9.21.1 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Basic Information
9.21.2 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Overview
9.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Market Performance
9.21.4 Rubius Therapeutics, Inc. Business Overview
9.21.5 Rubius Therapeutics, Inc. Recent Developments
9.22 Sangamo Therapeutics, Inc
9.22.1 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Basic Information
9.22.2 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product Overview
9.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product Market Performance
9.22.4 Sangamo Therapeutics, Inc Business Overview
9.22.5 Sangamo Therapeutics, Inc Recent Developments
9.23 Voyager Therapeutics, Inc
9.23.1 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Basic Information
9.23.2 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product Overview
9.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product Market Performance
9.23.4 Voyager Therapeutics, Inc Business Overview
9.23.5 Voyager Therapeutics, Inc Recent Developments
9.24 Waisman Biomanufacturing
9.24.1 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Basic Information
9.24.2 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product Overview
9.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product Market Performance
9.24.4 Waisman Biomanufacturing Business Overview
9.24.5 Waisman Biomanufacturing Recent Developments
9.25 WindMIL Therapeutics, Inc.
9.25.1 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Basic Information
9.25.2 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Overview
9.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Market Performance
9.25.4 WindMIL Therapeutics, Inc. Business Overview
9.25.5 WindMIL Therapeutics, Inc. Recent Developments
9.26 Wuxi App Tec, Inc.
9.26.1 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Basic Information
9.26.2 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product Overview
9.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product Market Performance
9.26.4 Wuxi App Tec, Inc. Business Overview
9.26.5 Wuxi App Tec, Inc. Recent Developments
9.27 ReNeuron Group plc
9.27.1 ReNeuron Group plc Cell Therapy and Tissue Engineering Basic Information
9.27.2 ReNeuron Group plc Cell Therapy and Tissue Engineering Product Overview
9.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Product Market Performance
9.27.4 ReNeuron Group plc Business Overview
9.27.5 ReNeuron Group plc Recent Developments
9.28 Richter-Helm BioLogics GmbH and Co. KG
9.28.1 Richter-Helm BioLogics GmbH and Co. KG Cell Therapy and Tissue Engineering Basic Information
9.28.2 Richter-Helm BioLogics GmbH and Co. KG Cell Therapy and Tissue Engineering Product Overview
9.28.3 Richter-Helm BioLogics GmbH and Co. KG Cell Therapy and Tissue Engineering Product Market Performance
9.28.4 Richter-Helm BioLogics GmbH and Co. KG Business Overview
9.28.5 Richter-Helm BioLogics GmbH and Co. KG Recent Developments
9.29 RoosterBio, Inc
9.29.1 RoosterBio, Inc Cell Therapy and Tissue Engineering Basic Information
9.29.2 RoosterBio, Inc Cell Therapy and Tissue Engineering Product Overview
9.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Product Market Performance
9.29.4 RoosterBio, Inc Business Overview
9.29.5 RoosterBio, Inc Recent Developments
9.30 RoslinCT
9.30.1 RoslinCT Cell Therapy and Tissue Engineering Basic Information
9.30.2 RoslinCT Cell Therapy and Tissue Engineering Product Overview
9.30.3 RoslinCT Cell Therapy and Tissue Engineering Product Market Performance
9.30.4 RoslinCT Business Overview
9.30.5 RoslinCT Recent Developments
10 Cell Therapy and Tissue Engineering Market Forecast by Region
10.1 Global Cell Therapy and Tissue Engineering Market Size Forecast
10.2 Global Cell Therapy and Tissue Engineering Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell Therapy and Tissue Engineering Market Size Forecast by Country
10.2.3 Asia Pacific Cell Therapy and Tissue Engineering Market Size Forecast by Region
10.2.4 South America Cell Therapy and Tissue Engineering Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell Therapy and Tissue Engineering by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Cell Therapy and Tissue Engineering Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cell Therapy and Tissue Engineering by Type (2025-2030)
11.1.2 Global Cell Therapy and Tissue Engineering Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cell Therapy and Tissue Engineering by Type (2025-2030)
11.2 Global Cell Therapy and Tissue Engineering Market Forecast by Application (2025-2030)
11.2.1 Global Cell Therapy and Tissue Engineering Sales (K Units) Forecast by Application
11.2.2 Global Cell Therapy and Tissue Engineering Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell Therapy and Tissue Engineering Market Size Comparison by Region (M USD)
Table 5. Global Cell Therapy and Tissue Engineering Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cell Therapy and Tissue Engineering Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cell Therapy and Tissue Engineering Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cell Therapy and Tissue Engineering Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Tissue Engineering as of 2022)
Table 10. Global Market Cell Therapy and Tissue Engineering Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cell Therapy and Tissue Engineering Sales Sites and Area Served
Table 12. Manufacturers Cell Therapy and Tissue Engineering Product Type
Table 13. Global Cell Therapy and Tissue Engineering Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cell Therapy and Tissue Engineering
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell Therapy and Tissue Engineering Market Challenges
Table 22. Global Cell Therapy and Tissue Engineering Sales by Type (K Units)
Table 23. Global Cell Therapy and Tissue Engineering Market Size by Type (M USD)
Table 24. Global Cell Therapy and Tissue Engineering Sales (K Units) by Type (2019-2024)
Table 25. Global Cell Therapy and Tissue Engineering Sales Market Share by Type (2019-2024)
Table 26. Global Cell Therapy and Tissue Engineering Market Size (M USD) by Type (2019-2024)
Table 27. Global Cell Therapy and Tissue Engineering Market Size Share by Type (2019-2024)
Table 28. Global Cell Therapy and Tissue Engineering Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cell Therapy and Tissue Engineering Sales (K Units) by Application
Table 30. Global Cell Therapy and Tissue Engineering Market Size by Application
Table 31. Global Cell Therapy and Tissue Engineering Sales by Application (2019-2024) & (K Units)
Table 32. Global Cell Therapy and Tissue Engineering Sales Market Share by Application (2019-2024)
Table 33. Global Cell Therapy and Tissue Engineering Sales by Application (2019-2024) & (M USD)
Table 34. Global Cell Therapy and Tissue Engineering Market Share by Application (2019-2024)
Table 35. Global Cell Therapy and Tissue Engineering Sales Growth Rate by Application (2019-2024)
Table 36. Global Cell Therapy and Tissue Engineering Sales by Region (2019-2024) & (K Units)
Table 37. Global Cell Therapy and Tissue Engineering Sales Market Share by Region (2019-2024)
Table 38. North America Cell Therapy and Tissue Engineering Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cell Therapy and Tissue Engineering Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cell Therapy and Tissue Engineering Sales by Region (2019-2024) & (K Units)
Table 41. South America Cell Therapy and Tissue Engineering Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cell Therapy and Tissue Engineering Sales by Region (2019-2024) & (K Units)
Table 43. Betalin Therapeutics Cell Therapy and Tissue Engineering Basic Information
Table 44. Betalin Therapeutics Cell Therapy and Tissue Engineering Product Overview
Table 45. Betalin Therapeutics Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Betalin Therapeutics Business Overview
Table 47. Betalin Therapeutics Cell Therapy and Tissue Engineering SWOT Analysis
Table 48. Betalin Therapeutics Recent Developments
Table 49. BioCardia, Inc Cell Therapy and Tissue Engineering Basic Information
Table 50. BioCardia, Inc Cell Therapy and Tissue Engineering Product Overview
Table 51. BioCardia, Inc Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. BioCardia, Inc Business Overview
Table 53. BioCardia, Inc Cell Therapy and Tissue Engineering SWOT Analysis
Table 54. BioCardia, Inc Recent Developments
Table 55. BioReliance Corporation Cell Therapy and Tissue Engineering Basic Information
Table 56. BioReliance Corporation Cell Therapy and Tissue Engineering Product Overview
Table 57. BioReliance Corporation Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. BioReliance Corporation Cell Therapy and Tissue Engineering SWOT Analysis
Table 59. BioReliance Corporation Business Overview
Table 60. BioReliance Corporation Recent Developments
Table 61. Biosolution Co. Cell Therapy and Tissue Engineering Basic Information
Table 62. Biosolution Co. Cell Therapy and Tissue Engineering Product Overview
Table 63. Biosolution Co. Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Biosolution Co. Business Overview
Table 65. Biosolution Co. Recent Developments
Table 66. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Basic Information
Table 67. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product Overview
Table 68. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Brainstorm Cell Therapeutics, Inc Business Overview
Table 70. Brainstorm Cell Therapeutics, Inc Recent Developments
Table 71. MaxCyte, Inc Cell Therapy and Tissue Engineering Basic Information
Table 72. MaxCyte, Inc Cell Therapy and Tissue Engineering Product Overview
Table 73. MaxCyte, Inc Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. MaxCyte, Inc Business Overview
Table 75. MaxCyte, Inc Recent Developments
Table 76. Medigene AG Cell Therapy and Tissue Engineering Basic Information
Table 77. Medigene AG Cell Therapy and Tissue Engineering Product Overview
Table 78. Medigene AG Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Medigene AG Business Overview
Table 80. Medigene AG Recent Developments
Table 81. MEDIPOST CO. Cell Therapy and Tissue Engineering Basic Information
Table 82. MEDIPOST CO. Cell Therapy and Tissue Engineering Product Overview
Table 83. MEDIPOST CO. Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. MEDIPOST CO. Business Overview
Table 85. MEDIPOST CO. Recent Developments
Table 86. Mesoblast Limited Cell Therapy and Tissue Engineering Basic Information
Table 87. Mesoblast Limited Cell Therapy and Tissue Engineering Product Overview
Table 88. Mesoblast Limited Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Mesoblast Limited Business Overview
Table 90. Mesoblast Limited Recent Developments
Table 91. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Basic Information
Table 92. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product Overview
Table 93. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Miromatrix Medical, Inc. Business Overview
Table 95. Miromatrix Medical, Inc. Recent Developments
Table 96. MolMed S.p.A Cell Therapy and Tissue Engineering Basic Information
Table 97. MolMed S.p.A Cell Therapy and Tissue Engineering Product Overview
Table 98. MolMed S.p.A Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. MolMed S.p.A Business Overview
Table 100. MolMed S.p.A Recent Developments
Table 101. Mustang Bio, Inc Cell Therapy and Tissue Engineering Basic Information
Table 102. Mustang Bio, Inc Cell Therapy and Tissue Engineering Product Overview
Table 103. Mustang Bio, Inc Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Mustang Bio, Inc Business Overview
Table 105. Mustang Bio, Inc Recent Developments
Table 106. NantKwest, Inc. Cell Therapy and Tissue Engineering Basic Information
Table 107. NantKwest, Inc. Cell Therapy and Tissue Engineering Product Overview
Table 108. NantKwest, Inc. Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. NantKwest, Inc. Business Overview
Table 110. NantKwest, Inc. Recent Developments
Table 111. Neuralstem, Inc Cell Therapy and Tissue Engineering Basic Information
Table 112. Neuralstem, Inc Cell Therapy and Tissue Engineering Product Overview
Table 113. Neuralstem, Inc Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Neuralstem, Inc Business Overview
Table 115. Neuralstem, Inc Recent Developments
Table 116. NexImmune, Inc. Cell Therapy and Tissue Engineering Basic Information
Table 117. NexImmune, Inc. Cell Therapy and Tissue Engineering Product Overview
Table 118. NexImmune, Inc. Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. NexImmune, Inc. Business Overview
Table 120. NexImmune, Inc. Recent Developments
Table 121. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Basic Information
Table 122. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product Overview
Table 123. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Nohla Therapeutics, Inc Business Overview
Table 125. Nohla Therapeutics, Inc Recent Developments
Table 126. ReNeuron Group plc Cell Therapy and Tissue Engineering Basic Information
Table 127. ReNeuron Group plc Cell Therapy and Tissue Engineering Product Overview
Table 128. ReNeuron Group plc Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. ReNeuron Group plc Business Overview
Table 130. ReNeuron Group plc Recent Developments
Table 131. Richter-Helm BioLogics GmbH and Co. KG Cell Therapy and Tissue Engineering Basic Information
Table 132. Richter-Helm BioLogics GmbH and Co. KG Cell Therapy and Tissue Engineering Product Overview
Table 133. Richter-Helm BioLogics GmbH and Co. KG Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Richter-Helm BioLogics GmbH and Co. KG Business Overview
Table 135. Richter-Helm BioLogics GmbH and Co. KG Recent Developments
Table 136. RoosterBio, Inc Cell Therapy and Tissue Engineering Basic Information
Table 137. RoosterBio, Inc Cell Therapy and Tissue Engineering Product Overview
Table 138. RoosterBio, Inc Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. RoosterBio, Inc Business Overview
Table 140. RoosterBio, Inc Recent Developments
Table 141. RoslinCT Cell Therapy and Tissue Engineering Basic Information
Table 142. RoslinCT Cell Therapy and Tissue Engineering Product Overview
Table 143. RoslinCT Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. RoslinCT Business Overview
Table 145. RoslinCT Recent Developments
Table 146. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Basic Information
Table 147. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Overview
Table 148. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Rubius Therapeutics, Inc. Business Overview
Table 150. Rubius Therapeutics, Inc. Recent Developments
Table 151. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Basic Information
Table 152. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product Overview
Table 153. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Sangamo Therapeutics, Inc Business Overview
Table 155. Sangamo Therapeutics, Inc Recent Developments
Table 156. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Basic Information
Table 157. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product Overview
Table 158. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Voyager Therapeutics, Inc Business Overview
Table 160. Voyager Therapeutics, Inc Recent Developments
Table 161. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Basic Information
Table 162. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product Overview
Table 163. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Waisman Biomanufacturing Business Overview
Table 165. Waisman Biomanufacturing Recent Developments
Table 166. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Basic Information
Table 167. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Overview
Table 168. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. WindMIL Therapeutics, Inc. Business Overview
Table 170. WindMIL Therapeutics, Inc. Recent Developments
Table 171. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Basic Information
Table 172. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product Overview
Table 173. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 174. Wuxi App Tec, Inc. Business Overview
Table 175. Wuxi App Tec, Inc. Recent Developments
Table 176. ReNeuron Group plc Cell Therapy and Tissue Engineering Basic Information
Table 177. ReNeuron Group plc Cell Therapy and Tissue Engineering Product Overview
Table 178. ReNeuron Group plc Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 179. ReNeuron Group plc Business Overview
Table 180. ReNeuron Group plc Recent Developments
Table 181. Richter-Helm BioLogics GmbH and Co. KG Cell Therapy and Tissue Engineering Basic Information
Table 182. Richter-Helm BioLogics GmbH and Co. KG Cell Therapy and Tissue Engineering Product Overview
Table 183. Richter-Helm BioLogics GmbH and Co. KG Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 184. Richter-Helm BioLogics GmbH and Co. KG Business Overview
Table 185. Richter-Helm BioLogics GmbH and Co. KG Recent Developments
Table 186. RoosterBio, Inc Cell Therapy and Tissue Engineering Basic Information
Table 187. RoosterBio, Inc Cell Therapy and Tissue Engineering Product Overview
Table 188. RoosterBio, Inc Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 189. RoosterBio, Inc Business Overview
Table 190. RoosterBio, Inc Recent Developments
Table 191. RoslinCT Cell Therapy and Tissue Engineering Basic Information
Table 192. RoslinCT Cell Therapy and Tissue Engineering Product Overview
Table 193. RoslinCT Cell Therapy and Tissue Engineering Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 194. RoslinCT Business Overview
Table 195. RoslinCT Recent Developments
Table 196. Global Cell Therapy and Tissue Engineering Sales Forecast by Region (2025-2030) & (K Units)
Table 197. Global Cell Therapy and Tissue Engineering Market Size Forecast by Region (2025-2030) & (M USD)
Table 198. North America Cell Therapy and Tissue Engineering Sales Forecast by Country (2025-2030) & (K Units)
Table 199. North America Cell Therapy and Tissue Engineering Market Size Forecast by Country (2025-2030) & (M USD)
Table 200. Europe Cell Therapy and Tissue Engineering Sales Forecast by Country (2025-2030) & (K Units)
Table 201. Europe Cell Therapy and Tissue Engineering Market Size Forecast by Country (2025-2030) & (M USD)
Table 202. Asia Pacific Cell Therapy and Tissue Engineering Sales Forecast by Region (2025-2030) & (K Units)
Table 203. Asia Pacific Cell Therapy and Tissue Engineering Market Size Forecast by Region (2025-2030) & (M USD)
Table 204. South America Cell Therapy and Tissue Engineering Sales Forecast by Country (2025-2030) & (K Units)
Table 205. South America Cell Therapy and Tissue Engineering Market Size Forecast by Country (2025-2030) & (M USD)
Table 206. Middle East and Africa Cell Therapy and Tissue Engineering Consumption Forecast by Country (2025-2030) & (Units)
Table 207. Middle East and Africa Cell Therapy and Tissue Engineering Market Size Forecast by Country (2025-2030) & (M USD)
Table 208. Global Cell Therapy and Tissue Engineering Sales Forecast by Type (2025-2030) & (K Units)
Table 209. Global Cell Therapy and Tissue Engineering Market Size Forecast by Type (2025-2030) & (M USD)
Table 210. Global Cell Therapy and Tissue Engineering Price Forecast by Type (2025-2030) & (USD/Unit)
Table 211. Global Cell Therapy and Tissue Engineering Sales (K Units) Forecast by Application (2025-2030)
Table 212. Global Cell Therapy and Tissue Engineering Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Cell Therapy and Tissue Engineering
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell Therapy and Tissue Engineering Market Size (M USD), 2019-2030
Figure 5. Global Cell Therapy and Tissue Engineering Market Size (M USD) (2019-2030)
Figure 6. Global Cell Therapy and Tissue Engineering Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell Therapy and Tissue Engineering Market Size by Country (M USD)
Figure 11. Cell Therapy and Tissue Engineering Sales Share by Manufacturers in 2023
Figure 12. Global Cell Therapy and Tissue Engineering Revenue Share by Manufacturers in 2023
Figure 13. Cell Therapy and Tissue Engineering Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cell Therapy and Tissue Engineering Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cell Therapy and Tissue Engineering Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cell Therapy and Tissue Engineering Market Share by Type
Figure 18. Sales Market Share of Cell Therapy and Tissue Engineering by Type (2019-2024)
Figure 19. Sales Market Share of Cell Therapy and Tissue Engineering by Type in 2023
Figure 20. Market Size Share of Cell Therapy and Tissue Engineering by Type (2019-2024)
Figure 21. Market Size Market Share of Cell Therapy and Tissue Engineering by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell Therapy and Tissue Engineering Market Share by Application
Figure 24. Global Cell Therapy and Tissue Engineering Sales Market Share by Application (2019-2024)
Figure 25. Global Cell Therapy and Tissue Engineering Sales Market Share by Application in 2023
Figure 26. Global Cell Therapy and Tissue Engineering Market Share by Application (2019-2024)
Figure 27. Global Cell Therapy and Tissue Engineering Market Share by Application in 2023
Figure 28. Global Cell Therapy and Tissue Engineering Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cell Therapy and Tissue Engineering Sales Market Share by Region (2019-2024)
Figure 30. North America Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cell Therapy and Tissue Engineering Sales Market Share by Country in 2023
Figure 32. U.S. Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cell Therapy and Tissue Engineering Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cell Therapy and Tissue Engineering Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cell Therapy and Tissue Engineering Sales Market Share by Country in 2023
Figure 37. Germany Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cell Therapy and Tissue Engineering Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cell Therapy and Tissue Engineering Sales Market Share by Region in 2023
Figure 44. China Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cell Therapy and Tissue Engineering Sales and Growth Rate (K Units)
Figure 50. South America Cell Therapy and Tissue Engineering Sales Market Share by Country in 2023
Figure 51. Brazil Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cell Therapy and Tissue Engineering Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cell Therapy and Tissue Engineering Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cell Therapy and Tissue Engineering Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cell Therapy and Tissue Engineering Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cell Therapy and Tissue Engineering Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cell Therapy and Tissue Engineering Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cell Therapy and Tissue Engineering Market Share Forecast by Type (2025-2030)
Figure 65. Global Cell Therapy and Tissue Engineering Sales Forecast by Application (2025-2030)
Figure 66. Global Cell Therapy and Tissue Engineering Market Share Forecast by Application (2025-2030)
